Norman Fields Gottscho Capital Management LLC Grows Stake in Roche Holding AG (OTCMKTS:RHHBY)

Norman Fields Gottscho Capital Management LLC grew its holdings in shares of Roche Holding AG (OTCMKTS:RHHBYFree Report) by 7.3% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 24,100 shares of the company’s stock after acquiring an additional 1,650 shares during the period. Norman Fields Gottscho Capital Management LLC’s holdings in Roche were worth $769,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds and other institutional investors have also recently modified their holdings of RHHBY. Wetzel Investment Advisors Inc. bought a new position in shares of Roche in the fourth quarter worth approximately $53,000. Rhumbline Advisers increased its stake in Roche by 11.2% in the 3rd quarter. Rhumbline Advisers now owns 96,751 shares of the company’s stock worth $3,283,000 after buying an additional 9,730 shares in the last quarter. OLD National Bancorp IN raised its holdings in Roche by 2.0% during the third quarter. OLD National Bancorp IN now owns 251,843 shares of the company’s stock valued at $8,619,000 after acquiring an additional 4,956 shares during the period. Ramirez Asset Management Inc. bought a new stake in Roche during the third quarter valued at about $2,575,000. Finally, Associated Banc Corp lifted its position in shares of Roche by 13.8% in the fourth quarter. Associated Banc Corp now owns 48,484 shares of the company’s stock valued at $1,761,000 after acquiring an additional 5,890 shares in the last quarter.

Roche Price Performance

Roche stock traded up $0.40 during mid-day trading on Wednesday, reaching $34.98. 2,874,023 shares of the company were exchanged, compared to its average volume of 2,436,845. Roche Holding AG has a 12-month low of $29.20 and a 12-month high of $40.15. The business has a fifty day moving average of $31.60 and a 200 day moving average of $33.22. The company has a quick ratio of 1.04, a current ratio of 1.35 and a debt-to-equity ratio of 0.75.

Wall Street Analyst Weigh In

RHHBY has been the topic of several research analyst reports. The Goldman Sachs Group assumed coverage on shares of Roche in a research note on Thursday, May 30th. They issued a “sell” rating on the stock. Argus reaffirmed a “hold” rating on shares of Roche in a report on Monday, March 4th. Finally, Deutsche Bank Aktiengesellschaft raised shares of Roche from a “sell” rating to a “hold” rating in a report on Friday, May 17th. Two analysts have rated the stock with a sell rating, five have given a hold rating and one has given a buy rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average target price of $40.00.

Check Out Our Latest Analysis on Roche

Roche Company Profile

(Free Report)

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation.

Further Reading

Institutional Ownership by Quarter for Roche (OTCMKTS:RHHBY)

Receive News & Ratings for Roche Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Roche and related companies with MarketBeat.com's FREE daily email newsletter.